Zejula 200 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FT4AL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,858
Award facts
- Contract value 100% obligated
- $24,858.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,858.24 to AmerisourceBergen Drug Corp for the supply of ZEJULA 200 mg tablets (30-count units) on November 13, 2025, with completion targeted for December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and operates as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and other federal health systems worldwide. ZEJULA, a specialty oncology medication, aligns with the company's portfolio of brand-name pharmaceuticals and advanced therapeutics delivered through the DLA Medical Supply Chain to support Defense Health Agency operations and other government healthcare customers.
Quick answers
Who was awarded contract SPE2DR26FT4AL?
SPE2DR26FT4AL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FT4AL worth?
The government has obligated $24,858 on SPE2DR26FT4AL.
Is contract SPE2DR26FT4AL an order under another contract?
Yes. SPE2DR26FT4AL is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT4AL competed?
The extent of competition for SPE2DR26FT4AL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award